Results 101 to 110 of about 4,735 (197)

MRI Regression Does Not Exclude Pathological Progression During Active Surveillance in Men Receiving Dutasteride

Objective To evaluate the biochemical, volumetric, radiologic, and pathological effects of dutasteride in men undergoing active surveillance (AS) for low-risk localized prostate cancer.
Muhammed Hilmi Enes Araci, Semih Aktas
core   +1 more source

The Effects of Dutasteride on Voiding and Storage Symptoms in Men with Benign Prostatic Hyperplasia [PDF]

, 2010
We investigated the effects of dutasteride on voiding and storage symptoms by a post-hoc analysis from two randomized, placebo-controlled, parallel-group studies (Japanese phase II study and phase III study) which assessed the efficacy and safety of ...
寺尾, 工, 秋山, 昭人, 塚本, 泰司, 遠藤, 之洋, 武内, 宏之, 矢島, 通孝, 酒本, 貞昭, 白井, 尚   +7 more
core  

Additional Administration of Dutasteride in Patients with Benign Prostatic Hyperplasia who Did Not Respond Sufficiently to α1-Adrenoceptor Antagonist : Investigation of Clinical Factors Affecting the Therapeutic Effect of Dutasteride [PDF]

, 2014
We performed additional administration of dutasteride in patients who did not respond sufficiently to α1-adrenoceptor antagonist treatment for lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) (LUTS/BPH).
黒田, 普之介, 河合, 正記, 横溝, 由美子, 中村, 麻美, 長田, 裕, 春日, 純, 野口, 剛, 村井, 哲夫, 増田, 光伸   +8 more
core  

Dehydroepiandrosterone Decline in Aging Males as a Predictor of Erectile Dysfunction and Mood Disorders in Patients With Benign Prostate Hyperplasia Undergoing Dutasteride Treatment

American Journal of Men's Health
Age-related decline in dehydroepiandrosterone (DHEA) and its sulfate metabolite, dehydroepiandrosterone-sulfate (DHEAS), affects steroid synthesis in men.
Maja Sofronievska Glavinov, Senol Tahir, Stefan Arsov   +2 more
doaj   +1 more source

Does Preoperative Use of Dutasteride Decrease Bleeding During Open Prostatectomy? [PDF]

, 2018
Purpose: To investigate whether use of dutasteride, a 5-alpha reductase inhibitor, for at least four weeks preoperatively affected the blood loss during open prostatectomy (OP).
Tepeler, Abdulkadir, Gulpinar, Murat Tolga, Kardas, Sina, Doluoglu, Omer Gokhan, Demirbas, Arif, Resorlu, Berkan, Kilinc, Muhammet Fatih   +6 more
core  

The Impact of Dutasteride Treatment on Subsequent Multiparametric Prostate Magnetic Resonance Imaging Sequences and PI-RADS Score in Patients With PI-RADS 3 Lesions in the Transitional Zone. [PDF]

Int J Urol
Sekkeli S, Erbin A, Erdal FS, Gursoy E, Dizdaroglu C, Turkay R.   +5 more
europepmc   +1 more source

Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review. [PDF]

Front Med (Lausanne)
Złotowska A, Jastrząb-Miśkiewicz B, Krajewski PK.   +2 more
europepmc   +1 more source

Dutasteride-loaded nanostructured lipid carrier for androgenic alopecia treatment - An <i>in vivo</i> study. [PDF]

Bioimpacts
Heydari S, Barzegar Jalali M, Kouhsoltani M, Radmehr A, Paiva-Santos AC, Barghi S, Hamishehkar H.   +6 more
europepmc   +1 more source

Drug combination choices of 5α-reductase inhibitors and α-blockers in patients with benign prostatic hyperplasia: a study based on the FAERS database. [PDF]

Front Med (Lausanne)
Qian J, Gong Y, Zhang C, Zhou L.
europepmc   +1 more source

5 Alpha Reductase Inhibitors (5ARIs) Monotherapy and Combinations: Current Role in Benign Prostatic Hyperplasia (BPH) Management. [PDF]

Medicina (Kaunas)
Roidos C, Sountoulides P, Papathanasiou K, Symeonidis A, Mykoniatis I.   +4 more
europepmc   +1 more source